LoDoCo2 (Completed) Low-dose colchicine for secondary prevention of cardiovascular disease – LoDoCo2 trial Medicine colchicine Population ASCVD Phase III Starting year 2016 More information LoDoCo2 website Publicaties LoDoCo2 Director of Study dr. A. Mosterd (Cardioloog) Amersfoort, Meander Medisch Centrum
